Course Overview

 Why choose this programme

The primary objective of this course is to provide formal training in cellular bioprocessing for clinical application for those who wish to study key emerging technologies for medical intervention. The course is designed according to Good Manufacturing Practices and provides a rigorous scientific underpinning for the development of a cellular therapy. 

 Cellular manufacturing and therapy and the production of advanced medicinal products (ATMPs), is quickly evolving as the future of medicine.

With the support and expertise located within the Centre for Cell Manufacturing Ireland, the Clinical Research Facility, the Translational Research Facility, the Regenerative Medicine Institute and the Galway Blood and Tissue Establishment, our students will have access to an internationally competitive MSc programme in Cellular Manufacturing and Therapy.

Allied NUI Galway course

  •  Microscopy and imaging of cells and tissue samples is a highly desirable skill for academia and industry alike.  Click here to learn more.


Applications and Selections

Who Teaches this Course

Janusz Krawczyk
Consultant Haematologist and Senior Lecturer

Cynthia Coleman
Research Fellow in Orthobiologics

Andrew Finnerty
General Manager of Centre for Cell Manufacturing Ireland

Sanbing Shen
Professor of Fundamental Stem Cell Biology

Timothy O’Brien
Professor of Medicine, Consultant Physician in Endocrinology and Director of Regenerative Medicine Institute

Linda Howard
Lecturer in Regenerative Medicine

Aoife Duffy
Production  Manager in Centre for Cell Manufacturing  Ireland

Mary Murphy
Senior Lecturer in Regenerative Medicine

Matt Griffin
Professor of Transplant Biology

Aideen Ryan
Research Fellow

Roisin Dwyer
Lecturer in Translational Medicine

Requirements and Assessment

Key Facts

Entry Requirements

Students must have completed one of the following ;
1) An undergraduate degree in medicine, pharmacy, manufacturing, biology, engineering.
2) An equivalent biomedical science-related undergraduate degree with a minimum of 2nd Class Honours. 

Applicants from non-biomedical science related backgrounds will be considered on a case-by-case basis at the discretion of the coordinators.  Students who have a degree without Honours in a related area and have 3+ years of practical experience in the subject area will also be considered for this programme. 

 For applicants where English is a second language, we will adhere to NUI Galway guidelines of requiring IELTS scores of 6.5, TOEFL scores of 88 and/or Pearson PTE scores of 61 with no less than 6.5 in any component.

 Initially a short listing procedure will be applied to prioritize applicants.  Those who do not meet the primary entry criteria as described above will be declined entry into the programme.  The remaining applicants will be reviewed in closer detail.  Significant weight will be placed on A) the applicant’s essay describing their motivation for applying for this course and their career aspirations following the successful completion of the MSc, B) the applicant’s referee’s comments and C) the applicant’s previous academic performance.  An interview may be conducted.

Additional Requirements


1 year full-time

Next start date

September 2018

A Level Grades ()

Average intake


Closing Date

Please refer to the review/closing date website.

Next start date

September 2018

NFQ level

Mode of study

ECTS weighting




PAC code


Course Outline

This is a one year full time course consisting of 90 ECTS.

Semester 1 (30 ECTS)
Core modules (20ECTS) in Cellular Manufacturing I, and Immune Cell Therapy as well as an elective module (10 ECTS) in Project Management, Molecular & Cellular Biology of Cancer, Economic Evaluation of Health Care, Introduction to Business or Fundamental Concepts in Pharmacology.

Semester 2 (30ECTS)
Compulsory modules in Cellular Manufacturing II, Mesenchymal Stem Cell Therapy and Induced Pluripotent Stem Cell Therapy.  These modules have both class room and laboratory based components.

Semester 3 (30 ECTS)
Compulsory dissertation to be completed by independent study.  This will consist of a literature review on cellular therapy, advanced cellular manufacturing (or comparable area) for publication in a relevant high-impact journal.

Why Choose This Course?

Career Opportunities

At NUI Galway, we are uniquely positioned to draw on existing expertise in science education, biomedical research, Good Manufacturing Practice (GMP)-grade cellular manufacturing and clinical translation of advanced therapeutics to educate future leaders in these emerging technologies.  

Graduates will be well positioned for careers in advanced medicinal therapy development or the manufacturing of ATMPs.

Who’s Suited to This Course

Learning Outcomes


Work Placement

Study Abroad

Related Student Organisations

Course Fees

Fees: EU

€8,500 p.a. 2018/19

Fees: Tuition

€8,276 p.a. 2018/19

Fees: Student levy

€224 p.a. 2018/19

Fees: Non EU

€17,000 p.a. 2018/19

Find out More

Cynthia Coleman
T: +353 91 495852

Janusz Krawczyk